Prostate Cancer Test Offers Early Prediction Of Bone Metastasis, Mortality

A prostate cancer test is best taken on a regular basis from the age of forty. A yearly test is generally enough due to the slow growing nature of Prostate cancer. By conducting check ups, the detection of the disease can be completed at a very early stage and needless to say, that the early stage detection might even give complete cure.Researchers and Scientists of John Hopkins Oncology Center have proved that the measuring of the chemical process linked with genetic change initiated with the prostate cancer makes early stage detection of prostate cancer. Always detection of cancer at preliminary stage facilitates complete cure. U.
S and U.K scientists are developing a test for prostate cancer using a sample of prostate fluid taken through a needle inserted under local anesthetic and takes less than three minutes to complete.
This will be a boon to the patients, health officials and Doctors.
A Prasanna de Silva, chair of the organic chemistry at Queen's University Belfast, U.K said that the new test was: " A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men". The most popular test for cancer throughout the world is the Prostate specific Antigen (PSA) prostate cancer test. Prostate gland secretes a protein called PSA and if the secretion value is high, it is indicative of the presence of cancer forming cells.
This test along with Digital Rectal Examination helps Physician to accurately measure the size of the prostate gland. Pharmaceuticals Scientists based at Maryland have identified a protein - HAAH enzyme might prove to be a biomarker, the sensitivity and specificity of which is much more accurate than the current methods for cancer detection.
This biomarker test will detect cancer very fast and hence will be useful in preventing prostate cancer recurrence. Swedish medical University Karolinska Institutet scientists have identified risk genes through a simple DNA test and hope that men carrying a known combination of risk genes run 4 to 5 times higher risk of prostate cancer.
They say that the risk of prostate cancer recurrence is there even in the cases of unfinished cures. Now let us look at the nanoparticle prostate cancer test.
Here the golden nanoparticles are first mixed in a solution.
Then the patrient's blood is dropped in the nano solution. Then the nano particles seek put the protein.
In case of protein particles being present, then the protein particles surrounded by the nanoparticles.
When there is cluster formation, cancer is present, is the inference. Otherwise in case of no cluster formation, obviously no cancer formation needs to be suspected.
The question whether obesity is an impediment for prostate cancer test has been studied deeply by the Texas University Health Science Center in San Antonio.
They concluded that in obese men the sensitivity of PSA testing is blunted.
What the Doctors conclude is that more estrogen is produced by obese men, affecting testosterone levels and could affect the cells that produce antigen in the test.

Be sure to check out OnProstateCancer.com for comprehensive Prostate Cancer Test information, or to find all the Prostate Cancer Recurrence advice and insights that you need. Follow the links right now !